Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Hepatocellular × alectinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Thyroid Neoplasms 2 Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Cancer, Papillary 1 Thoracic Neoplasms 1 Sarcoma 1 Salivary Gland Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Neoplasms 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Colorectal Neoplasms 1 Colonic Diseases 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Bronchogenic 1

Interventions

Sorafenib 49 pembrolizumab 20 Nivolumab 18 Bevacizumab 16 Radiosurgery 15 Doxorubicin 12 lenvatinib 8 Erlotinib Hydrochloride 7 atezolizumab 6 Ramucirumab 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 tremelimumab 5 durvalumab 5 cabozantinib 5 Radiofrequency Ablation 5 tislelizumab 4 Sunitinib 4 Ipilimumab 4 regorafenib 3 nintedanib 3 carotuximab 3 bavituximab 3 Ribavirin 3 Radiotherapy 3 Oxaliplatin 3 Mitomycin 3 Leucovorin 3 Fluorouracil 3 Everolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡